Award

Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection

PUBLIC HEALTH ENGLAND

This public procurement record has 1 release in its history.

Award

24 Sep 2018 at 12:58

Award Notice
Summary of the contracting process

The procurement process involves Public Health England awarding a contract titled "Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection". This contract relates to the healthcare industry and is based in London, United Kingdom. The procurement stage is complete, with the contract awarded on 21 September 2018 after a limited negotiated procedure without prior publication. The value of the contract is £38,100, and it will be in effect from 21 September 2018 to 21 September 2019, having a tender period that ended on 10 September 2018.

This tender creates opportunities for businesses in the diagnostic kits sector, particularly those specialising in health monitoring and testing equipment. As Sedia Biosciences Corporation has been awarded the contract solely due to their unique product offerings, other companies with similar technological capabilities or solutions in diagnostic assays could consider engaging in future procurements in this area. Firms experienced in providing high-quality healthcare products may find this an advantageous market to explore.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection

Notice Description

Public Health England (PHE) has awarded a contract for the provision of H1V-1 LAg-Avidity ElA kits to Sedia Biosciences Corporation, which is used to monitor recent HIV infection in people in newly diagnosed with HIV as part of national Surveillances. To ensure comparability of data, the same assay is required over time to minimise any variation between assays performance. Sedia LAg assays are used to monitor recent infections in the UK. Sedia Biosciences Corporation is the only manufacturer of the Sedia LAg assay. Alternative LAg assays have been shown to have different performance characteristics following evaluation. Sufficient data have been generated on the Sedia LAg assay to confirm that it meets our performance characteristics and that these data are in line with that published by the manufacturer including an MDRI of approx. 130 days at a normalised ODn of 1.5. Additional information: VEAT notice details: OJEU Document Number 2018/S 167-380498 Notice Reference 2018-041795

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-571977b1-74d3-40ed-b59c-48d90ccf06e8
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/64977ca2-4d68-4a4a-a6bb-04de76d3b1c8
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Negotiated procedure without prior publication (above threshold)
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33141625 - Diagnostic kits

Notice Value(s)

Tender Value
£38,100 Under £100K
Lots Value
Not specified
Awards Value
£38,100 Under £100K
Contracts Value
Not specified

Notice Dates

Publication Date
24 Sep 20187 years ago
Submission Deadline
10 Sep 2018Expired
Future Notice Date
Not specified
Award Date
20 Sep 20187 years ago
Contract Period
20 Sep 2018 - 21 Sep 2019 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
PUBLIC HEALTH ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
NW9 5EQ
Post Town
North West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI7 Outer London - West and North West
Small Region (ITL 3)
TLI71 Barnet
Delivery Location
TLI London
Local Authority
Barnet
Electoral Ward
Colindale South
Westminster Constituency
Hendon

Supplier Information

Number of Suppliers
1
Supplier Name

SEDIA BIOSCIENCES

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-571977b1-74d3-40ed-b59c-48d90ccf06e8-2018-09-24T13:58:43+01:00",
    "date": "2018-09-24T13:58:43+01:00",
    "ocid": "ocds-b5fd17-571977b1-74d3-40ed-b59c-48d90ccf06e8",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "tender_126614/714178",
        "title": "Contract Award for the provision of H1V-1 LAg-Avidity ElA to Determine Recency of Infection",
        "description": "Public Health England (PHE) has awarded a contract for the provision of H1V-1 LAg-Avidity ElA kits to Sedia Biosciences Corporation, which is used to monitor recent HIV infection in people in newly diagnosed with HIV as part of national Surveillances. To ensure comparability of data, the same assay is required over time to minimise any variation between assays performance. Sedia LAg assays are used to monitor recent infections in the UK. Sedia Biosciences Corporation is the only manufacturer of the Sedia LAg assay. Alternative LAg assays have been shown to have different performance characteristics following evaluation. Sufficient data have been generated on the Sedia LAg assay to confirm that it meets our performance characteristics and that these data are in line with that published by the manufacturer including an MDRI of approx. 130 days at a normalised ODn of 1.5. Additional information: VEAT notice details: OJEU Document Number 2018/S 167-380498 Notice Reference 2018-041795",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33141625",
            "description": "Diagnostic kits"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 38100,
            "currency": "GBP"
        },
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated procedure without prior publication (above threshold)",
        "tenderPeriod": {
            "endDate": "2018-09-10T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2018-09-21T00:00:00+01:00",
            "endDate": "2019-09-21T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-42572",
            "name": "Public Health England",
            "identifier": {
                "legalName": "Public Health England"
            },
            "address": {
                "streetAddress": "61 Colindale Avenue",
                "locality": "London",
                "postalCode": "NW9 5EQ",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "imran.rahman@phe.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-96685",
            "name": "Sedia Biosciences Corporation",
            "identifier": {
                "legalName": "Sedia Biosciences Corporation"
            },
            "address": {
                "streetAddress": "4900 NE 122nd Avenue Portland, OR 97230-1049 US"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-42572",
        "name": "Public Health England"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-571977b1-74d3-40ed-b59c-48d90ccf06e8-1",
            "status": "active",
            "date": "2018-09-21T00:00:00+01:00",
            "datePublished": "2018-09-24T13:58:43+01:00",
            "value": {
                "amount": 38100,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-96685",
                    "name": "Sedia Biosciences Corporation"
                }
            ],
            "contractPeriod": {
                "startDate": "2018-09-21T00:00:00+01:00",
                "endDate": "2019-09-21T23:59:59+01:00"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/64977ca2-4d68-4a4a-a6bb-04de76d3b1c8",
                    "datePublished": "2018-09-24T13:58:43+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}